We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current ORMP market cap is 95.15M. The company's latest EPS is USD 0.1371 and P/E is 17.36.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 287k | 0 | 0 | 0 |
| Operating Income | -2.89M | -3.59M | -2.96M | -3.14M | -3.09M |
| Net Income | -3.22M | 13.34M | 1.54M | 9.21M | -19.62M |
| Year End December 30 2023 | 2020 | 2021 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 2.71M | 2.7M | 904k | 2.7M | 1.63M |
| Operating Income | -11.76M | -24.22M | -12.33M | -40.6M | -15.77M |
| Net Income | -11.51M | -24.99M | -11.67M | -36.56M | 5.53M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 230.89M | 220.55M | 203.65M | 184.22M | 165.08M |
| Total Liabilities | 82.66M | 57.66M | 37.93M | 8.07M | 9.56M |
| Total Equity | 148.23M | 162.89M | 165.72M | 176.15M | 155.52M |
| Year End December 30 2023 | 2020 | 2021 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 44.63M | 128M | 177.82M | 161.64M | 220.55M |
| Total Liabilities | 11.75M | 11.48M | 11.21M | 10.49M | 57.66M |
| Total Equity | 32.88M | 116.52M | 166.61M | 151.16M | 162.89M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -8.88M | -10.3M | -1.48M | 600k | -6.5M |
| Investing | -103.04M | -73.04M | 30M | 124.65M | 90.39M |
| Financing | 76.98M | 51.98M | -19M | -49.55M | -50.84M |
| Year End December 30 2023 | 2020 | 2021 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -12.44M | -21.18M | -11.12M | -27.92M | -10.3M |
| Investing | 4.63M | -23.76M | -99.25M | 30.21M | -73.04M |
| Financing | 23.79M | 102.89M | 60.57M | 10.78M | 51.98M |
| Market Cap | 95.15M |
| Price to Earnings Ratio | 17.36 |
| Price to Sales Ratio | 58.91 |
| Price to Cash Ratio | 10.6 |
| Price to Book Ratio | 0.59 |
| Dividend Yield | - |
| Shares Outstanding | 40.31M |
| Average Volume (1 week) | 233.4k |
| Average Volume (1 Month) | 224.72k |
| 52 Week Change | 5.84% |
| 52 Week High | 3.67 |
| 52 Week Low | 2.00 |
| Spread (Intraday) | 0.19 (7.45%) |
| Company Name | Oramed Pharmaceuticals Inc |
| Address |
llc, 1013 center road jerusalem, jerusalem 19805 |
| Website | https://www.oramed.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
